NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » iMET--Institute of Molecular & Experimental Th back to previous page show list

iMET--Institute of Molecular & Experimental Th

address: No.118 Longtan Road
Suzhou Industrial Park
Jiangsu Province
P.R.China
contact:
key person: Co-Directors:
•Dr. JieWang, Physiology/Pharmacology/Medicine
•Dr. JianningLiu, Molecular Biology

trunover in millions USD: 0
R & D turnover in millions USD: 0
NET profit: 0
year of financial results:
employees: 0

active in China: YES

SFDA approved: NO

Approvals:
GLP: NO
GMP: NO
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: YES
Ingredients: YES
Western Generics: YES
TCM: NO

R & D:
Discovery: NO
Work Up (pilot to production): NO
Analysis: YES
Quality Control: YES
Stability: YES
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: NO
Support Labs: NO

Non clinical & preclinical:
Animal Testing: GLP: YES
New materials Safety Assessment: YES
Pharmaceuticals: YES
Agrochemicals: NO
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: NO

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 
iMET Mission
 
Develop the premier Chinese preclinical contract services firm for pharmaceutical companies in the U.S. and European Union by leveraging cost advantages with proprietary know-how and expertise of our scientific team.
 
Service Structure
 
Shanghai
l          1200 sq. meter facility
l          Therapeutic Pharmacology
l          Electric physiology
l          Synthetic/analytical chemistry
l          Research & service
l          20 Scientists and Staffs
 
Suzhou
l          2500 sq. meter facility
l          Pre-clinical CRO service
l          35 Scientist and Staffs
Management Components
l          GLP/QA/QC Office
l          Legal Office
l          IACUC
l          Management Office
l          Veterinary Support
 
Nanjing
l          2000 sq. meter facility
l          Molecular Medicine
l          Recombinant Proteins & peptides
l          Research & Service
30 Scientists and Staffs
Services:
 
Suzhou
 
Efficacy & Safety Evaluation Platform
 
•Cardiovascular
•Immunology
•Oncology
•Toxicity
•PK
•Metabolism
•Histo-pathology
 
Nanjing
 
Molecular Medicine
Platform
Proteins & Peptides Platform
 
Shanghai
 
Therapeutic Pharmacology
Research & Services
 
•hERG Safety Screening
•Oncology
•Cardiovascular
•Neurology
•Chemical synthesis
•Analytical Chemistry
 
 
iMET Current Offerings
 
Suzhou
 
Identifying indications and proper animal disease models for proteins/peptides/chemical compounds and medical devices
•ADME Determining timing, dosing, and administrative path
•Experimental Therapeutics: Identifying and determining mechanisms
•API synthesis: Contract manufacturing of protein/peptide drugs
•Optimizing protein/peptide productions
•Proof of Concept, Safety Pharmacology, Toxicology and PK
•Concept approval, optimizing design and pre-IND package for clinical trials for medical devices
 
iMET Team Members and Team
 
Senior Personnel with over 20+ years experience in U.S., expertise in small and large animal therapeutic pharmacology studies with both NCEs and medical devices. The company has a team of investigators who have experience in GLP, GMP, AAALAC, and regulatory affairs in both US and China.
Co-Directors:
•Dr. JieWang, Physiology/Pharmacology/Medicine
•Dr. JianningLiu, Molecular Biology
 
Teams:
•Cardiovascular
•Immunology
•Oncology
•Metabolism
•Histopathology
•Synthetic/Analytic Chemistry
•Veterinary Support
•QA/QC
 

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.